Rho-kinase inhibitor decreased pulmonary artery resistance, whereas increased compliance in a rat model of pulmonary hypertension

Takuya Nishikawa, Keita Saku, takafumi sakamoto, Yasuhiro Oga, Takeshi Tohyama, Takuya Kishi, Kenji Sunagawa

Research output: Contribution to journalArticle

Abstract

Although the dynamic mechanical properties such as arterial compliance (C) have been shown to predict increased mortality in patients with pulmonary arterial hypertension (PAH), a simple static index, i.e., pulmonary arterial resistance (R) has been exclusively used in clinical settings. We examined how a Rho-kinase inhibitor, fasudil, that is known to suppress vasoconstriction, affects pulmonary artery input impedance (Z) in Sugen/Hypoxia (SuHx) PAH in rats. We measured Z before PAH induction (Normal), and re-measured before/after fasudil injection (10 mg/kg) (PAH/Fasudil). PAH increased R while Fasudil decreased R (Normal: 16.3±2.6, PAH: 56.5±6.9, Fasudil: 39.9±5.2 mmHg/ml/sec, p<0.01). In contrast, PAH decreased C while Fasudil increased C (Normal: 3.6±0.6, PAH: 1.8±0.4, Fasudil: 2.5±0.8 ×103 ml/mmHg, p<0.01). We conclude that the pulmonary arterial impedance may serve as a new tool in analyzing vascular mechanics to assess the severity or the drug efficacy in PAH patients.

Original languageEnglish
Pages (from-to)1-2
Number of pages2
JournalTransactions of Japanese Society for Medical and Biological Engineering
Volume54
Issue numberPROC
Publication statusPublished - 2016

Fingerprint

Rats
Mechanics
Mechanical properties
Compliance
Vasoconstriction

All Science Journal Classification (ASJC) codes

  • Biomedical Engineering

Cite this

Rho-kinase inhibitor decreased pulmonary artery resistance, whereas increased compliance in a rat model of pulmonary hypertension. / Nishikawa, Takuya; Saku, Keita; sakamoto, takafumi; Oga, Yasuhiro; Tohyama, Takeshi; Kishi, Takuya; Sunagawa, Kenji.

In: Transactions of Japanese Society for Medical and Biological Engineering, Vol. 54, No. PROC, 2016, p. 1-2.

Research output: Contribution to journalArticle

@article{587c925f07804eb19f623c44bdab72a6,
title = "Rho-kinase inhibitor decreased pulmonary artery resistance, whereas increased compliance in a rat model of pulmonary hypertension",
abstract = "Although the dynamic mechanical properties such as arterial compliance (C) have been shown to predict increased mortality in patients with pulmonary arterial hypertension (PAH), a simple static index, i.e., pulmonary arterial resistance (R) has been exclusively used in clinical settings. We examined how a Rho-kinase inhibitor, fasudil, that is known to suppress vasoconstriction, affects pulmonary artery input impedance (Z) in Sugen/Hypoxia (SuHx) PAH in rats. We measured Z before PAH induction (Normal), and re-measured before/after fasudil injection (10 mg/kg) (PAH/Fasudil). PAH increased R while Fasudil decreased R (Normal: 16.3±2.6, PAH: 56.5±6.9, Fasudil: 39.9±5.2 mmHg/ml/sec, p<0.01). In contrast, PAH decreased C while Fasudil increased C (Normal: 3.6±0.6, PAH: 1.8±0.4, Fasudil: 2.5±0.8 ×103 ml/mmHg, p<0.01). We conclude that the pulmonary arterial impedance may serve as a new tool in analyzing vascular mechanics to assess the severity or the drug efficacy in PAH patients.",
author = "Takuya Nishikawa and Keita Saku and takafumi sakamoto and Yasuhiro Oga and Takeshi Tohyama and Takuya Kishi and Kenji Sunagawa",
year = "2016",
language = "English",
volume = "54",
pages = "1--2",
journal = "BME = Bio medical engineering / henshu, Nihon ME Gakkai",
issn = "1347-443X",
publisher = "Japanese Society for Medical and Biological Engineering",
number = "PROC",

}

TY - JOUR

T1 - Rho-kinase inhibitor decreased pulmonary artery resistance, whereas increased compliance in a rat model of pulmonary hypertension

AU - Nishikawa, Takuya

AU - Saku, Keita

AU - sakamoto, takafumi

AU - Oga, Yasuhiro

AU - Tohyama, Takeshi

AU - Kishi, Takuya

AU - Sunagawa, Kenji

PY - 2016

Y1 - 2016

N2 - Although the dynamic mechanical properties such as arterial compliance (C) have been shown to predict increased mortality in patients with pulmonary arterial hypertension (PAH), a simple static index, i.e., pulmonary arterial resistance (R) has been exclusively used in clinical settings. We examined how a Rho-kinase inhibitor, fasudil, that is known to suppress vasoconstriction, affects pulmonary artery input impedance (Z) in Sugen/Hypoxia (SuHx) PAH in rats. We measured Z before PAH induction (Normal), and re-measured before/after fasudil injection (10 mg/kg) (PAH/Fasudil). PAH increased R while Fasudil decreased R (Normal: 16.3±2.6, PAH: 56.5±6.9, Fasudil: 39.9±5.2 mmHg/ml/sec, p<0.01). In contrast, PAH decreased C while Fasudil increased C (Normal: 3.6±0.6, PAH: 1.8±0.4, Fasudil: 2.5±0.8 ×103 ml/mmHg, p<0.01). We conclude that the pulmonary arterial impedance may serve as a new tool in analyzing vascular mechanics to assess the severity or the drug efficacy in PAH patients.

AB - Although the dynamic mechanical properties such as arterial compliance (C) have been shown to predict increased mortality in patients with pulmonary arterial hypertension (PAH), a simple static index, i.e., pulmonary arterial resistance (R) has been exclusively used in clinical settings. We examined how a Rho-kinase inhibitor, fasudil, that is known to suppress vasoconstriction, affects pulmonary artery input impedance (Z) in Sugen/Hypoxia (SuHx) PAH in rats. We measured Z before PAH induction (Normal), and re-measured before/after fasudil injection (10 mg/kg) (PAH/Fasudil). PAH increased R while Fasudil decreased R (Normal: 16.3±2.6, PAH: 56.5±6.9, Fasudil: 39.9±5.2 mmHg/ml/sec, p<0.01). In contrast, PAH decreased C while Fasudil increased C (Normal: 3.6±0.6, PAH: 1.8±0.4, Fasudil: 2.5±0.8 ×103 ml/mmHg, p<0.01). We conclude that the pulmonary arterial impedance may serve as a new tool in analyzing vascular mechanics to assess the severity or the drug efficacy in PAH patients.

UR - http://www.scopus.com/inward/record.url?scp=85009914417&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009914417&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85009914417

VL - 54

SP - 1

EP - 2

JO - BME = Bio medical engineering / henshu, Nihon ME Gakkai

JF - BME = Bio medical engineering / henshu, Nihon ME Gakkai

SN - 1347-443X

IS - PROC

ER -